The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial (PACIFY)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.
Also called NCT02683707
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 212 participants
- Sponsor
- Registry
-
NCT02683707
-
- Other papers using this trial's data
- Fentanyl Delays the Platelet Inhibition Effects of Oral Ticagrelor: Full Report of the PACIFY Randomized Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02683707. Randomized; single masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2017-05-25 (actual). Results posted on 2018-05-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial (PACIFY)
- Acronym
- PACIFY
- Condition
- Coronary Artery Disease
- Intervention (Other)
- Removal of Fentanyl from peri-procedural analgesia
- Intervention (Drug)
- Fentanyl
- Intervention (Drug)
- Lidocaine
- Intervention (Drug)
- Midazolam
- Lead sponsor
- Johns Hopkins University
Record details
- Record id
cardio:ct-nct02683707- Content hash
803c5a21145be7e42ccbe7e07188848dd5cad82a96c73e5905f6d6902756ceda